Codeine can't do it: Fatal forty DDI: Codeine, fluoxetine, CYP2D6

Katarina Bojanić, Wayne T. Nicholson, Erica D. Wittwer, Toby N. Weingarten, Juraj Sprung

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

This case discusses a pharmacokinetic interaction between the prodrug codeine and fluoxetine. Codeine is converted to its active metabolite morphine by cytochrome P450 2D6. Fluoxetine is a 2D6 inhibitor.

Original languageEnglish (US)
Title of host publicationA Case Approach to Perioperative Drug-Drug Interactions
PublisherSpringer New York
Pages269-273
Number of pages5
ISBN (Print)9781461474951, 9781461474944
DOIs
StatePublished - Sep 15 2015

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Codeine can't do it: Fatal forty DDI: Codeine, fluoxetine, CYP2D6'. Together they form a unique fingerprint.

  • Cite this

    Bojanić, K., Nicholson, W. T., Wittwer, E. D., Weingarten, T. N., & Sprung, J. (2015). Codeine can't do it: Fatal forty DDI: Codeine, fluoxetine, CYP2D6. In A Case Approach to Perioperative Drug-Drug Interactions (pp. 269-273). Springer New York. https://doi.org/10.1007/978-1-4614-7495-1_56